News

The dose escalation and safety trial will expand to two centres in Atlanta and Ann Arbor, subject to approval by the Institutional Review Board at each institution. Neuralstem

As per the agreement, Myriad will adopt RainDance’s ThunderStorm Target Enrichment System for its next-generation sequencing based Hereditary Cancer Panel (HCP) test. Myriad Genetics president Mark Capone said

The company developed VizuCELL cell lines as a tool to study temporal and spatial dynamic processes in living cells. The tool provides insights into morphological changes and physiological

PET tracers are aimed to image tau (or neurofibrillary) tangles in the brain, one of two known hallmarks of Alzheimer’s disease. Initially Lilly will integrate the new technology

The company is planning to equip its national sales force with StayinFront TouchRx on iPads and management team with StayinFront EdgeRx . SaaS-based StayinFront’s EdgeRx and TouchRx provide

Cetrotide is used in women undergoing infertility treatment for the regulation of hormone responses. Presently, Merck Serono is marketing the product across the world except Japan. The transaction,

As part of the synergy, the companies will launch hybrid business model. Ranbaxy will support Daiichi Sankyo Brasil Farmaceutica, Daiichi Sankyo’s Brazilian subsidiary, to enter into branded generics

Investigational drug Ruconest 50 U/kg is being developed for the treatment of acute angioedema attacks in patients with hereditary angioedema (HAE). A Phase III randomized placebo-controlled study conducted

In pre-clinical asthma models ASM-024 exhibited the capabilities of inhibitory effects on inflammation, bronchoprotection and smooth muscle relaxation. Asmacure founder and chief medical officer Yvon Cormier said the